-
1.发明申请公开(公告)号：US20120064169A1
公开(公告)日：2012-03-15
申请号：US13220356
申请日：2011-08-29
Applicant: R. Holland Cheng , Li Xing , Tatsuo Miyamura , Yasuhiro Yasutomi , Tian-Cheng Li , Naokazu Takeda
Inventor： R. Holland Cheng , Li Xing , Tatsuo Miyamura , Yasuhiro Yasutomi , Tian-Cheng Li , Naokazu Takeda
CPC classification number: A61K39/21 , A61K39/12 , A61K39/29 , A61K2039/5258 , A61K2039/541 , A61K2039/542 , C07K14/005 , C07K2319/40 , C12N2740/16122 , C12N2740/16134 , C12N2740/16234 , C12N2770/28123 , C12N2770/28134 , C12N2770/28142
Abstract: This invention provides a peptide/nucleic acid composition for oral/mucosal, dual-modal activation of immune protection systems.
Abstract translation: 本发明提供了用于免疫保护系统的口腔/粘膜，双重模态激活的肽/核酸组合物。
-
2.发明授权Process and apparatus for producing hydrocarbons from residential trash or waste and/or organic waste materials 失效从住宅垃圾或废物和/或有机废物生产碳氢化合物的工艺和设备
公开(公告)号：US06133491A
公开(公告)日：2000-10-17
申请号：US204078
申请日：1998-12-03
Applicant: Li Xing
Inventor： Li Xing
CPC classification number: C10G1/02 , C10B47/30 , C10G1/08 , F23G5/20 , F23G2203/211
Abstract: The invention provides a process and apparatus for producing hydrocarbons from residential trash or waste and/or organic waste materials. In particular, the invention provides a process and apparatus for producing hydrocarbons from residential trash or waste and/or organic waste materials in virtue of pyrolysis and catalytic cracking.
Abstract translation: 本发明提供了一种用于从住宅垃圾或废物和/或有机废物生产碳氢化合物的方法和装置。 特别地，本发明提供了由于热解和催化裂化而从住宅垃圾或废物和/或有机废物生产碳氢化合物的方法和装置。
-
3.发明申请PROTEOLYSIS-RESISTANT CAPSID OF CHIMERIC HEPATITIS E VIRUS AS AN ORAL DELIVERY VECTOR 有权作为口服递送载体的重型乙型肝炎病毒的抗肿瘤药物公开(公告)号：US20120301494A1
公开(公告)日：2012-11-29
申请号：US13224151
申请日：2011-09-01
Applicant: R. Holland Cheng , Li Xing
Inventor： R. Holland Cheng , Li Xing
CPC classification number: C07K14/005 , A61K9/5184 , A61K39/00 , A61K39/12 , A61K39/21 , A61K39/29 , A61K2039/5258 , A61K2039/53 , A61K2039/541 , A61K2039/542 , C07K16/10 , C07K16/1063 , C07K2317/34 , C07K2317/55 , C07K2317/76 , C07K2319/00 , C07K2319/40 , C12N7/00 , C12N2710/14143 , C12N2740/16122 , C12N2740/16134 , C12N2740/16234 , C12N2770/28123 , C12N2770/28134 , C12N2770/28142
Abstract: This invention provides a peptide/nucleic acid composition for oral/mucosal, dual-modal activation of immune protection systems.
Abstract translation: 本发明提供了用于免疫保护系统的口腔/粘膜，双重模态激活的肽/核酸组合物。
-
公开(公告)号：US20070088033A1
公开(公告)日：2007-04-19
申请号：US11531492
申请日：2006-09-13
Applicant: Balekudru Devadas , John Walker , Shaun Selness , Terri Boehm , Richard Durley , Rajesh Devraj , Brian Hickory , Paul Rucker , Kevin Jerome , Heather Madsen , Edgardo Alvira , Michele Promo , Radhika Blevis-Bal , Laura Marruto , Jeff Hitchcock , Thomas Owen , Win Naing , Li Xing , Huey Shieh , Aruna Sambandam , Shuang Liu , Ian Scott , Kevin McGee
Inventor： Balekudru Devadas , John Walker , Shaun Selness , Terri Boehm , Richard Durley , Rajesh Devraj , Brian Hickory , Paul Rucker , Kevin Jerome , Heather Madsen , Edgardo Alvira , Michele Promo , Radhika Blevis-Bal , Laura Marruto , Jeff Hitchcock , Thomas Owen , Win Naing , Li Xing , Huey Shieh , Aruna Sambandam , Shuang Liu , Ian Scott , Kevin McGee
IPC: A61K31/53 , A61K31/506 , A61K31/497 , A61K31/4439 , A61K31/4545 , A61K31/4709 , C07D417/02 , C07D403/02 , C07D401/02
CPC classification number: C07D213/64 , C07D213/69 , C07D213/70 , C07D213/74 , C07D213/75 , C07D213/79 , C07D213/84 , C07D213/85 , C07D215/22 , C07D401/04 , C07D401/06 , C07D401/10 , C07D401/12 , C07D401/14 , C07D405/04 , C07D405/06 , C07D405/12 , C07D405/14 , C07D409/06 , C07D409/14 , C07D413/10
Abstract: Disclosed are compounds Formula I and pharmaceutically acceptable salts thereof, wherein R1, R2, R3, R4, and R5 are defined herein. These compounds are useful for treating diseases and conditions caused or exacerbated by unregulated p38 MAP Kinase and/or TNF activity. Pharmaceutical compositions containing the compounds, methods of preparing the compounds and methods of treatment using the compounds are also disclosed.
Abstract translation: 公开了式I化合物及其药学上可接受的盐，其中R 1，R 2，R 3，R 4， >和R 5＆gt;在本文中定义。 这些化合物可用于治疗由不受调节的p38 MAP激酶和/或TNF活性引起或加重的疾病和病症。 还公开了含有化合物的药物组合物，制备化合物的方法和使用该化合物的治疗方法。
-
公开(公告)号：US20060211694A1
公开(公告)日：2006-09-21
申请号：US11226556
申请日：2005-09-14
Applicant: Balekudru Devadas , John Walker , Shaun Selness , Terri Boehm , Richard Durley , Rajesh Devraj , Brian Hickory , Paul Rucker , Kevin Jerome , Heather Madsen , Edgardo Alvira , Michele Promo , Radhika Blevis-Bal , Laura Marruto , Jeff Hitchcock , Thomas Owen , Win Naing , Li Xing , Huey Shieh , Aruna Sambandam , Shuang Liu , Ian Scott , Kevin McGee
Inventor： Balekudru Devadas , John Walker , Shaun Selness , Terri Boehm , Richard Durley , Rajesh Devraj , Brian Hickory , Paul Rucker , Kevin Jerome , Heather Madsen , Edgardo Alvira , Michele Promo , Radhika Blevis-Bal , Laura Marruto , Jeff Hitchcock , Thomas Owen , Win Naing , Li Xing , Huey Shieh , Aruna Sambandam , Shuang Liu , Ian Scott , Kevin McGee
IPC: A61K31/53 , A61K31/506 , A61K31/498 , A61K31/497 , A61K31/501 , A61K31/4439 , A61K31/4747 , A61K31/4709 , A61K31/4412
CPC classification number: C07D213/64 , C07D213/69 , C07D213/70 , C07D213/74 , C07D213/75 , C07D213/79 , C07D213/84 , C07D213/85 , C07D215/22 , C07D401/04 , C07D401/06 , C07D401/10 , C07D401/12 , C07D401/14 , C07D405/04 , C07D405/06 , C07D405/12 , C07D405/14 , C07D409/06 , C07D409/14 , C07D413/10
Abstract: Disclosed are compounds Formula I and pharmaceutically acceptable salts thereof, wherein R1, R2, R3, R4, and R5 are defined herein. These compounds are useful for treating diseases and conditions caused or exacerbated by unregulated p38 MAP Kinase and/or TNF activity. Pharmaceutical compositions containing the compounds, methods of preparing the compounds and methods of treatment using the compounds are also disclosed.
Abstract translation: 公开了式I化合物及其药学上可接受的盐，其中R 1，R 2，R 3，R 4， >和R 5＆gt;在本文中定义。 这些化合物可用于治疗由不受调节的p38 MAP激酶和/或TNF活性引起或加重的疾病和病症。 还公开了含有化合物的药物组合物，制备化合物的方法和使用该化合物的治疗方法。
-
Patent Agency Ranking
公开(公告)号：US07067540B2
公开(公告)日：2006-06-27
申请号：US10367987
申请日：2003-02-14
Applicant: Balekudru Devadas , John Walker , Shaun R. Selness , Terri L. Boehm , Richard C. Durley , Rajesh Devraj , Brian S. Hickory , Paul V. Rucker , Kevin D. Jerome , Heather M. Madsen , Edgardo Alvira , Michele A. Promo , Radhika M. Blevis-Bal , Laura D. Marruto , Jeff Hitchcock , Thomas Owen , Win Naing , Li Xing , Huey S. Shieh , Aruna Sambandam , Shuang Liu , Ian L. Scott , Kevin F. McGee
Inventor： Balekudru Devadas , John Walker , Shaun R. Selness , Terri L. Boehm , Richard C. Durley , Rajesh Devraj , Brian S. Hickory , Paul V. Rucker , Kevin D. Jerome , Heather M. Madsen , Edgardo Alvira , Michele A. Promo , Radhika M. Blevis-Bal , Laura D. Marruto , Jeff Hitchcock , Thomas Owen , Win Naing , Li Xing , Huey S. Shieh , Aruna Sambandam , Shuang Liu , Ian L. Scott , Kevin F. McGee
IPC: A61K31/44 , C07D213/02 , C07D401/02
CPC classification number: C07D213/64 , C07D213/69 , C07D213/70 , C07D213/74 , C07D213/75 , C07D213/79 , C07D213/84 , C07D213/85 , C07D215/22 , C07D401/04 , C07D401/06 , C07D401/10 , C07D401/12 , C07D401/14 , C07D405/04 , C07D405/06 , C07D405/12 , C07D405/14 , C07D409/06 , C07D409/14 , C07D413/10
Abstract: Disclosed are compounds Formula I and pharmaceutically acceptable salts thereof, wherein R1, R2, R3, R4, and R5 are defined herein. These compounds are useful for treating diseases and conditions caused or exacerbated by unregulated p38 MAP Kinase and/or TNF activity. Pharmaceutical compositions containing the compounds, methods of preparing the compounds and methods of treatment using the compounds are also disclosed.
Abstract translation: 公开了式I化合物及其药学上可接受的盐，其中R 1，R 2，R 3，R 4， >和R 5＆gt;在本文中定义。 这些化合物可用于治疗由不受调节的p38 MAP激酶和/或TNF活性引起或加重的疾病和病症。 还公开了含有化合物的药物组合物，制备化合物的方法和使用该化合物的治疗方法。
-
公开(公告)号：US20050176775A1
公开(公告)日：2005-08-11
申请号：US10918826
申请日：2004-08-13
Applicant: Balekudru Devadas , John Walker , Shaun Selness , Terri Boehm , Richard Durley , Rajesh Devraj , Brian Hickory , Paul Rucker , Kevin Jerome , Heather Madsen , Edgardo Alvira , Michele Promo , Radhika Blevis-Bal , Laura Marrufo , Jeff Hitchcock , Thomas Owen , Win Naing , Li Xing , Huey Shieh , Aruna Sambandam , Shuang Liu , Ian Scott , Kevin McGee
Inventor： Balekudru Devadas , John Walker , Shaun Selness , Terri Boehm , Richard Durley , Rajesh Devraj , Brian Hickory , Paul Rucker , Kevin Jerome , Heather Madsen , Edgardo Alvira , Michele Promo , Radhika Blevis-Bal , Laura Marrufo , Jeff Hitchcock , Thomas Owen , Win Naing , Li Xing , Huey Shieh , Aruna Sambandam , Shuang Liu , Ian Scott , Kevin McGee
IPC: A61K20060101 , A61K31/4412 , A61K31/4415 , A61K31/4439 , A61P29/00 , C07D211/86 , C07D213/64 , C07D213/69 , C07D213/70 , C07D213/73 , C07D213/74 , C07D213/75 , C07D213/80 , C07D213/84 , C07D215/22 , C07D401/04 , C07D401/06 , C07D401/10 , C07D401/12 , C07D401/14 , C07D405/04 , C07D405/06 , C07D405/12 , C07D405/14 , C07D409/04 , C07D409/06 , C07D409/12 , C07D409/14 , C07D413/06 , C07D413/10 , C07D417/04 , C07D41/02
CPC classification number: C07D213/69 , C04B35/632 , C07D213/64 , C07D213/70 , C07D213/73 , C07D213/80 , C07D215/22 , C07D401/04 , C07D401/06 , C07D401/10 , C07D401/12 , C07D401/14 , C07D405/04 , C07D405/06 , C07D405/12 , C07D405/14 , C07D409/04 , C07D409/06 , C07D409/12 , C07D409/14 , C07D413/06 , C07D413/10 , C07D417/04
Abstract: Disclosed are compounds of Formula I and pharmaceutically acceptable salts thereof, wherein R1, R2, R3, R4, and R5 are defined herein. These compounds are useful for treating diseases and conditions caused or exacerbated by unregulated p38 MAP Kinase and/or TNF activity. Pharmaceutical compositions containing the compounds, methods of preparing the compounds and methods of treatment using the compounds are also disclosed.
Abstract translation: 公开了式I的化合物及其药学上可接受的盐，其中R 1，R 2，R 3，R 4， SUB＆gt;和R 5＆gt;在本文中定义。 这些化合物可用于治疗由不受调节的p38 MAP激酶和/或TNF活性引起或加重的疾病和病症。 还公开了含有化合物的药物组合物，制备化合物的方法和使用该化合物的治疗方法。
-
8.发明授权公开(公告)号：US08906862B2
公开(公告)日：2014-12-09
申请号：US13220356
申请日：2011-08-29
Applicant: R. Holland Cheng , Li Xing , Tatsuo Miyamura , Yasuhiro Yasutomi , Tian-Cheng Li , Naokazu Takeda
Inventor： R. Holland Cheng , Li Xing , Tatsuo Miyamura , Yasuhiro Yasutomi , Tian-Cheng Li , Naokazu Takeda
IPC: A61K38/16 , C07K14/005 , A61K39/29 , A61K39/21 , A61K39/00
CPC classification number: A61K39/21 , A61K39/12 , A61K39/29 , A61K2039/5258 , A61K2039/541 , A61K2039/542 , C07K14/005 , C07K2319/40 , C12N2740/16122 , C12N2740/16134 , C12N2740/16234 , C12N2770/28123 , C12N2770/28134 , C12N2770/28142
Abstract: This invention provides a peptide/nucleic acid composition for oral/mucosal, dual-modal activation of immune protection systems.
Abstract translation: 本发明提供了用于免疫保护系统的口腔/粘膜，双重模态激活的肽/核酸组合物。
-
公开(公告)号：US20120060665A1
公开(公告)日：2012-03-15
申请号：US13218016
申请日：2011-08-25
Applicant: Li Xing , Wei Dai , Shaojun Wang
Inventor： Li Xing , Wei Dai , Shaojun Wang
IPC: B23D59/00
CPC classification number: B23D59/00 , B25H1/0078 , Y10T83/8763 , Y10T83/8878
Abstract: A guiding mechanism for an electric tool includes at least two guiding elements at least one of which has a first end portion having at least one protruding portion extending outwards therefrom and the other of which has a second end portion having at least one groove therein which may be engaged with the protruding portion. The groove has a cut-out and the protruding portion has an elastic clamping portion which may be engaged with the cut-out.
Abstract translation: 电动工具的引导机构包括至少两个引导元件，其中至少一个引导元件具有第一端部部分，该第一端部部分具有从其向外延伸的至少一个突出部分，另一个引导元件具有第二端部，其中至少一个凹槽 与突出部分接合。 凹槽具有切口，并且突出部分具有可与切口接合的弹性夹持部分。
-
公开(公告)号：USD638680S1
公开(公告)日：2011-05-31
申请号：US29365299
申请日：2010-07-07
Applicant: Li Xing , David Allan
Designer： Li Xing , David Allan
-
-
-
-
-
-
-
-
-
Search Results
29
records
(took 0.061 seconds)
